Cytokines as a key component of cancer-related inflammation

被引：278

作者：

Germano, Giovanni ^{[1
]}

Allavena, Paola ^{[1
]}

Mantovani, Alberto ^{[1
,2
,3
]}

机构：

[1] Ist Clin Humanitas IRCCS, I-20089 Milan, Italy

[2] Fdn Humanitas Ric, I-20089 Milan, Italy

[3] Univ Milan, Inst Gen Pathol, Milan, Italy

来源：

CYTOKINE | 2008年 / 43卷 / 03期

关键词：

Cancer-related; Inflammation; Tumor-associated macrophages; Cytokines; Chemokines;

D O I：

10.1016/j.cyto.2008.07.014

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Inflammatory conditions in some tissues increase the risk of cancer. Cytokines and chemokines are components of an intensive dialog promoting angiogenesis, metastasis, subversion of adaptive immunity and changing response to hormones and to chemotherapeutic agents. Cytokines involved in cancer-related inflammation represent a target for innovative diagnostic and therapeutic strategies, and a future challenge for scientists and clinicians. (C) 2008 Elsevier Ltd. All rights reserved.

引用

收藏

页码：374 / 379

页数：6

相关论文

共 85 条

[31] Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family [J].

Garlanda, Cecilia ;

Riva, Federica ;

Veliz, Tania ;

Polentarutti, Nadia ;

Pasqualini, Fabio ;

Radaelli, Enrico ;

Sironi, Marina ;

Nebuloni, Manuela ;

Zorini, Elisabetta Omodeo ;

Scanziani, Eugenio ;

Mantovani, Alberto .

CANCER RESEARCH, 2007, 67 (13) :6017-6021

[32]

GIAVAZZI R, 1990, CANCER RES, V50, P4771

[33] Tolerance, DCs and tryptophan: much ado about IDO [J].

Grohmann, U ;

Fallarino, F ;

Puccetti, P .

TRENDS IN IMMUNOLOGY, 2003, 24 (05) :242-248

[34] Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection [J].

Guiducci, C ;

Vicari, AP ;

Sangaletti, S ;

Trinchieri, G ;

Colombo, MP .

CANCER RESEARCH, 2005, 65 (08) :3437-3446

[35] Tumor necrosis factor α as a new target for renal cell carcinoma:: Two sequential phase II trials of infliximab at standard and high dose [J].

Harrison, Michelle L. ;

Obermueller, Eva ;

Maisey, Nick R. ;

Hoare, Susan ;

Edmonds, Kim ;

Li, Ningfeng F. ;

Chao, David ;

Hall, Kate ;

Lee, Chooi ;

Timotheadou, Eleni ;

Charles, Kellie ;

Ahern, Roger ;

King, D. Mike ;

Eisen, Tim ;

Corringham, Robert ;

DeWitte, Mark ;

Balkwill, Frances ;

Gore, Martin .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4542-4549

[36]

Hotchkiss KA, 2003, CANCER RES, V63, P527

[37] IL-6 in autoimmune disease and chronic inflammatory proliferative disease [J].

Ishihara, K ;

Hirano, T .

CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :357-368

[38] Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents [J].

Joseph, IBJK ;

Isaacs, JT .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21) :1648-1653

[39]

KAKUMU S, 1991, AM J GASTROENTEROL, V86, P1804

[40] VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche [J].

Kaplan, RN ;

Riba, RD ;

Zacharoulis, S ;

Bramley, AH ;

Vincent, L ;

Costa, C ;

MacDonald, DD ;

Jin, DK ;

Shido, K ;

Kerns, SA ;

Zhu, ZP ;

Hicklin, D ;

Wu, Y ;

Port, JL ;

Altorki, N ;

Port, ER ;

Ruggero, D ;

Shmelkov, SV ;

Jensen, KK ;

Rafii, S ;

Lyden, D .

NATURE, 2005, 438 (7069) :820-827

← 1 2 3 4 5 6 7 8 9 →